Topic: How To Invest

Could I have your analysis and comments on Repligen Corporation? Thanks.

Article Excerpt

Repligen, $7.84, symbol RGEN on Nasdaq (Shares outstanding: 31.4 million; Market cap: $246.5 million; www.repligen.com), develops, makes and sells consumable products for making drugs. The company’s clients include major life-sciences and biopharmaceutical firms around the world. Repligen is a leading maker of Protein A, which is used to separate and purify antibodies for treating diseases. The company also supplies several products that make cell cultures more productive during the fermentation stage of drug manufacturing. In addition, Repligen has developed and markets OPUS, a series of chromatography columns. (Column chromatography uses large glass tubes filled with an absorbent material, such as silica gel or alumina, to separate individual chemical compounds from mixtures.) The company also provides test kits to check the quality of the final product. In the three months ended March 31, 2013, Repligen’s revenue rose 31.8%, to $16.5 million from $12.8 million a year earlier. Earnings per share rose 75%, to $0.07 from $0.04. The company holds cash of $54.1 million, or…